Managing and Optimizing Clinical Supply in the Clinical Trial Market in China

Life Sciences, Clinical Trials,
  • Wednesday, October 19, 2022

China has become an important destination for clinical trials. What are the trends and challenges when conducting clinical trials in China? What are the important considerations to successfully supply clinical trials in China? This webinar will highlight the latest developments of the clinical trial industry in China and share experiences to optimize clinical supply chain in China. The featured speakers will discuss how to put together a strategy and solution that can work best for supply chain and logistics in the clinical trial market in China.

Register to learn more about managing and optimizing clinical supply in China.


Dan Gourley, Sharp Clinical

Dan Gourley, Sr. Director of Global Logistics, Sharp Clinical

As Sr. Director of Global Logistics, Dan is responsible for the oversight of global clinical supply and IRT services at Sharp. He has over 20 years of clinical trial experience, beginning his career in finance before moving into logistics. Dan has led and participated in many complex projects including ERP implementation, site closures, site construction, due diligence and VAT analysis.

Message Presenter
Paul Cao, ClinsChain

Paul Cao, Founder and General Manager, ClinsChain

Paul (Yufeng) Cao is the Founder and current General Manager of ClinsChain. Since its establishment in 2018, ClinsChain has rapidly grown into a major clinical trial supply service provider based in China and covering both at home and abroad, providing one-stop professional clinical trial supply services including drug/material procurement, primary packaging, secondary packaging, warehousing, logistics, import and export, clinical supply management, regulatory consultation, etc.

Paul Cao is a veteran in the clinical trial supply service and pharmaceutical supply chain industry. He has worked in this field for more than 20 years and has extensive experience in clinical supply management services, supply chain of pharmaceutical products, GXP regulations and other related fields. He worked in Zuellig Pharma China between 2002 to 2009 and undertook various operation management responsibilities. From 2009 to 2013, he served as the General Manager for Fisher Clinical Services in China. From 2013 to 2017, he served as the Operation Director and General Manager for the Clinical Supply Services division of Catalent Pharma Solutions in China, responsible for the company start-up, daily operation and overall management of the company.

Paul Cao has a Bachelor of Science from Beijing University of Science and Technology. He also holds a Master of Business Administration from Vlerick Leuven Gent Management School, K. U. Leuven, Belgium, and a master’s in computer science & artificial intelligence from K. U. Leuven, Belgium.

Message Presenter

Who Should Attend?

  • Clinical Operations
  • Clinical Supply
  • Demand Planners, Distribution and Logistics
  • Clinical Study Managers
  • Clinical IRT specialists
  • Clinical Outsourcing

What You Will Learn

Attendees will gain insights into:

  • The trends of the clinical trial market in China
  • The challenges including those brought over by China’s COVID-19 control policy
  • The latest local GMP requirement on preparing an investigational medicinal product (IMP)
  • What to consider when conducting clinical research in China
  • Importing into China

Xtalks Partner


Sharp is a global leader in clinical supply chain services and pharmaceutical packaging. For more than 65 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. Learn more at

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account